<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31957062</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>27</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1531-8249</ISSN><JournalIssue CitedMedium="Internet"><Volume>87</Volume><Issue>4</Issue><PubDate><Year>2020</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Annals of neurology</Title><ISOAbbreviation>Ann Neurol</ISOAbbreviation></Journal><ArticleTitle>Clinical and Molecular Aspects of Senataxin Mutations in Amyotrophic Lateral Sclerosis 4.</ArticleTitle><Pagination><StartPage>547</StartPage><EndPage>555</EndPage><MedlinePgn>547-555</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/ana.25681</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To determine the clinical and molecular features in patients with amyotrophic lateral sclerosis 4 (ALS4) due to mutations in the senataxin (SETX) gene and to develop tools for evaluating SETX variants.</AbstractText><AbstractText Label="METHODS">Our study involved 32 patients, including 31 with mutation in SETX at c.1166 T&gt;C (p.Leu389Ser) and 1 with mutation at c.1153 G&gt;A (p.Glu385Lys). Clinical characterization of the patients included neurological examination, blood tests, magnetic resonance imaging (MRI), and dual-energy x-ray absorptiometry (DEXA). Fibroblasts and motor neurons were obtained to model the disease and characterize the molecular alteration in senataxin function.</AbstractText><AbstractText Label="RESULTS">We report key clinical features of ALS4. Laboratory analysis showed alteration of serum creatine kinase and creatinine in the Leu389Ser ALS4 cohort. MRI showed increased muscle fat fraction in the lower extremities, which correlates with disease duration (thigh fat fraction R<sup>2</sup> = 0.35, p = 0.01; lower leg fat fraction R<sup>2</sup> = 0.49, p&#x2009;&lt;&#x2009;0.01). DEXA measurements showed lower extremities are more affected than upper extremities (average fat z scores of 2.1 and 0.6, respectively). A cellular assay for SETX function confirmed that like the Leu389Ser mutation, the Glu385Lys variant leads to a decrease in R loops, likely from a gain of function.</AbstractText><AbstractText Label="INTERPRETATION">We identified clinical laboratory and radiological features of ALS4, and hence they should be monitored for disease progression. The molecular characterization of R-loop levels in patient-derived cells provides insight into the disease pathology and assays to evaluate the pathogenicity of candidate mutations in the SETX gene. ANN NEUROL 2020;87:547-555.</AbstractText><CopyrightInformation>&#xa9; 2020 The Authors. Annals of Neurology published by Wiley Periodicals, Inc. on behalf of American Neurological Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Grunseich</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-4994-2472</Identifier><AffiliationInfo><Affiliation>Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patankar</LastName><ForeName>Aneesh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amaya</LastName><ForeName>Joshua</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watts</LastName><ForeName>Jason A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Michigan, Ann Arbor, MI.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Dongjun</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Life Sciences Institute, University of Michigan, Ann Arbor, MI.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, Chevy Chase, MD.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramirez</LastName><ForeName>Prisila</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Life Sciences Institute, University of Michigan, Ann Arbor, MI.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schindler</LastName><ForeName>Alice B</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fischbeck</LastName><ForeName>Kenneth H</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheung</LastName><ForeName>Vivian G</ForeName><Initials>VG</Initials><AffiliationInfo><Affiliation>Life Sciences Institute, University of Michigan, Ann Arbor, MI.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, Chevy Chase, MD.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, University of Michigan, Ann Arbor, MI.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>01</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Neurol</MedlineTA><NlmUniqueID>7707449</NlmUniqueID><ISSNLinking>0364-5134</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064251">Multifunctional Enzymes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.3.2</RegistryNumber><NameOfSubstance UI="D003402">Creatine Kinase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="C484368">SETX protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.-</RegistryNumber><NameOfSubstance UI="D004265">DNA Helicases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.13</RegistryNumber><NameOfSubstance UI="D020365">RNA Helicases</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C566550">Amyotrophic Lateral Sclerosis 4, Juvenile</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015502" MajorTopicYN="N">Absorptiometry, Photon</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000273" MajorTopicYN="N">Adipose Tissue</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003402" MajorTopicYN="N">Creatine Kinase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004265" MajorTopicYN="N">DNA Helicases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004576" MajorTopicYN="N">Electromyography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005347" MajorTopicYN="N">Fibroblasts</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="N">Induced Pluripotent Stem Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035002" MajorTopicYN="N">Lower Extremity</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064251" MajorTopicYN="N">Multifunctional Enzymes</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009431" MajorTopicYN="N">Neural Conduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000080870" MajorTopicYN="N">R-Loop Structures</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020365" MajorTopicYN="N">RNA Helicases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034941" MajorTopicYN="N">Upper Extremity</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Nothing to report.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>10</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>12</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>1</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31957062</ArticleId><ArticleId IdType="pmc">PMC7818251</ArticleId><ArticleId IdType="doi">10.1002/ana.25681</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ghasemi M, Brown RH Jr. Genetics of amyotrophic lateral sclerosis. Cold Spring Harb Perspect Med 2018;8:a024125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5932579</ArticleId><ArticleId IdType="pubmed">28270533</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitcho MA, Baloh RH, Chakraverty S, et al. TDP&#x2010;43 A315T mutation in familial motor neuron disease. Ann Neurol 2008;63:535&#x2013;538.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2747362</ArticleId><ArticleId IdType="pubmed">18288693</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski TJ Jr, Bosco DA, Leclerc AL, et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 2009;323:1205&#x2013;1208.</Citation><ArticleIdList><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HJ, Kim NC, Wang YD, et al. Mutations in prion&#x2010;like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature 2013;495:467&#x2013;473.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3756911</ArticleId><ArticleId IdType="pubmed">23455423</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YZ, Bennett CL, Huynh HM, et al. DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am J Hum Genet 2004;74:1128&#x2013;1135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1182077</ArticleId><ArticleId IdType="pubmed">15106121</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabin BA, Griffin JW, Crain BJ, et al. Autosomal dominant juvenile amyotrophic lateral sclerosis. Brain 1999;122:1539&#x2013;1550.</Citation><ArticleIdList><ArticleId IdType="pubmed">10430837</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirano M, Quinzii CM, Mitsumoto H, et al. Senataxin mutations and amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2011;12:223&#x2013;227.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7528023</ArticleId><ArticleId IdType="pubmed">21190393</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassuk AG, Chen YZ, Batish SD, et al. In cis autosomal dominant mutation of senataxin associated with tremor/ataxia syndrome. Neurogenetics 2007;8:45&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">17096168</ArticleId></ArticleIdList></Reference><Reference><Citation>Phansalskar N, More S, Sabale A, et al. Adaptive local thresholding for detection of nuclei in diversity stained cytology images. International Conference on Communications and Signal Processing (ICCSP). Piscataway, NJ: IEEE, 2011:218&#x2013;220.</Citation></Reference><Reference><Citation>Kelly TL, Wilson KE, Heymfield SB. Dual energy x&#x2010;ray absorptiometry body composition reference values from NHANES. PLoS One 2009;4:e7038.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2737140</ArticleId><ArticleId IdType="pubmed">19753111</ArticleId></ArticleIdList></Reference><Reference><Citation>Grunseich C, Wang IX, Watts JA, et al. Senataxin mutation reveals how R&#x2010;loops promote transcription by blocking DNA methylation at gene promoters. Mol Cell 2018;69:426&#x2013;437.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5815878</ArticleId><ArticleId IdType="pubmed">29395064</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandopulle MS, Prestil R, Grunseich C, et al. Transcription factor&#x2010;mediated differentiation of human iPSCs into neurons. Curr Protoc Cell Biol 2018;79:e51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6993937</ArticleId><ArticleId IdType="pubmed">29924488</ArticleId></ArticleIdList></Reference><Reference><Citation>Haruki M, Noguchi E, Kanaya S, Crouch RJ. Kinetic and stoichiometric analysis for the binding of Escherichia coli ribonuclease HI to RNA&#x2010;DNA hybrids using surface plasmon resonance. J Biol Chem 1997;272:22015&#x2013;22022.</Citation><ArticleIdList><ArticleId IdType="pubmed">9268340</ArticleId></ArticleIdList></Reference><Reference><Citation>
American Cancer Society
. Cancer facts and figures 2019. Updated 2019. Available at: http://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2019/cancer-facts-and-figures-2019.pdf. Accessed July 1, 2019.</Citation></Reference><Reference><Citation>
NIH National Cancer Institute
. The cancer genome atlas program. Available at: http://www.cancergenome.nih.gov. Accessed June 1, 2018.</Citation></Reference><Reference><Citation>Arber S, Han B, Mendelsohn M, et al. Requirement for the homeobox gene Hb9 in the consolidation of motor neuron identity. Neuron 1999;23:659&#x2013;674.</Citation><ArticleIdList><ArticleId IdType="pubmed">10482234</ArticleId></ArticleIdList></Reference><Reference><Citation>Carriedo SG, Yin HZ, Weiss JH. Motor neurons are selectively vulnerable to AMPA/kainite receptor&#x2010;mediated injury in vitro. J Neurosci 1996;16:4069&#x2013;4079.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6578994</ArticleId><ArticleId IdType="pubmed">8753869</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HD, Choe J, Seo YS. The sen1(+) gene of Schizosaccharomyces pombe, a homologue of budding yeast SEN1, encodes an RNA and DNA helicase. Biochemistry 1999;38:14697&#x2013;14710.</Citation><ArticleIdList><ArticleId IdType="pubmed">10545196</ArticleId></ArticleIdList></Reference><Reference><Citation>Skourti&#x2010;Stathaki K, Proudfoot NJ, Gromak N. Human senataxin resolves RNA/DNA hybrids formed at transcriptional pause sites to promote Xrn2&#x2010;dependent termination. Mol Cell 2011;42:794&#x2013;805.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3145960</ArticleId><ArticleId IdType="pubmed">21700224</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Z, Zhang A, Storz G, Gottesman S, Leppla SH. An antibody&#x2010;based microarray assay for small RNA detection. Nucleic Acids Res 2006;34:e52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1435976</ArticleId><ArticleId IdType="pubmed">16614443</ArticleId></ArticleIdList></Reference><Reference><Citation>Avemaria F, Lunetta C, Tarlarini C, et al. Mutation in the senataxin gene found in a patient affected by familial ALS with juvenile onset and slow progression. Amyotroph Lateral Scler 2011;12:228&#x2013;230.</Citation><ArticleIdList><ArticleId IdType="pubmed">21438761</ArticleId></ArticleIdList></Reference><Reference><Citation>Rafiq MK, Lee E, Bradburn M, et al. Creatine kinase enzyme level correlates positively with serum creatinine and lean body mass, and is a prognostic factor for survival in amyotrophic lateral sclerosis. Eur J Neurol 2016;23:1071&#x2013;1078.</Citation><ArticleIdList><ArticleId IdType="pubmed">27029589</ArticleId></ArticleIdList></Reference><Reference><Citation>Patin F, Corcia P, Madji Hounoum B, et al. Biological follow&#x2010;up in amyotrophic lateral sclerosis: decrease in creatinine levels and increase in ferritin levels predict poor prognosis. Eur J Neurol 2015;22:1385&#x2013;1390.</Citation><ArticleIdList><ArticleId IdType="pubmed">26095828</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashizume A, Katsuno M, Banno H, et al. Longitudinal changes of outcome measures in spinal and bulbar muscular atrophy. Brain 2012;135:2838&#x2013;2848.</Citation><ArticleIdList><ArticleId IdType="pubmed">22773541</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahlqvist JR, Oestergaard ST, Poulsen NS, et al. Refining the spinobulbar muscular atrophy phenotype by quantitative MRI and clinical assessments. Neurology 2019;92:e548&#x2013;e559.</Citation><ArticleIdList><ArticleId IdType="pubmed">30610091</ArticleId></ArticleIdList></Reference><Reference><Citation>Mushtaq Z, Choudhury SD, Gangwar SK, et al. Human senataxin modulates structural plasticity of the neuromuscular junction in drosophila through a neuronally conserved TGF&#x3b2; signaling pathway. Neurodegener Dis 2016;16:324&#x2013;336.</Citation><ArticleIdList><ArticleId IdType="pubmed">27197982</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakashima H, Tsujimura K, Irie K, et al. Canonical TGF&#x2010;&#x3b2; signaling negatively regulates neuronal morphogenesis through TGFIF/Smad complex&#x2010;mediated CRMP2 suppression. J Neurosci 2018;38:4791&#x2013;4810.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6596019</ArticleId><ArticleId IdType="pubmed">29695415</ArticleId></ArticleIdList></Reference><Reference><Citation>Endo F, Komine O, Fujimori&#x2010;Tonou N, et al. Astrocyte&#x2010;derived TGF&#x2010;&#x3b2;1 accelerates disease progression in ALS mice by interfering with the neuroprotective functions of microglia and T cells. Cell Rep 2015;11:592&#x2013;604.</Citation><ArticleIdList><ArticleId IdType="pubmed">25892237</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>